Liver cirrhosis treatment market is estimated to reach approximately $15 billion in the U.S. by 2030 Ramat Gan, Israel, Feb.

Can-Fite BioPharma (CANF) announced a significant clinical development: the disappearance of episodes of decompensated liver cirrhosis ...

Assessment of liver fibrosis and cirrhosis is crucial for the management of patients with chronic hepatitis B. The presence of at least moderate liver fibrosis is an important indication for antiviral ...

Liver cancer is the sixth most frequent cancer worldwide, mainly represented by hepatocellular carcinoma, accounting for ...

Innovative therapies and surgical techniques have the potential to transform liver cancer care. People with cirrhosis—a ...

Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...

Coffee has anti-inflammatory anti-fibrotic and antioxidant properties which help in boosting liver health Read this article ...

At a three-day event, hepatology experts focused on improving patient outcomes, particularly in ICU care, while exploring ...

The study, led by researchers from the INSERM, the French National Institute of Health and Medical Research, focused on ...

Nearly 4 in 10 American adults are estimated to have a liver condition that can lead to serious complications and even death.